4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-001018
Options or other derivatives
- CHIEF BUSINESS OFFICER acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Snow David P. CHIEF BUSINESS OFFICER | 2019-09-12 | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | D: show line 1 in the form |
Loading xslF345X03/form4-09132019_040911.xml…